Latest News - Presbia

Monday, October 02, 2017 | Cataract Surgery, Conferences, Presbia

Presbia Announces Several Presentations at the European Society of Cataract & Refractive Surgeons and in the International Society of Presbyopia 2017

Presbia will participate at the XXXV Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), Europe’s leading organization for cataract and refractive surgeons, to be held …

Read the full story

Thursday, September 08, 2016 | Conferences, Presbia

Presbia Announces Presentations at ESCRS and in the International Society of Presbyopia 2016

Presbia will participate in the XXXIV Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), Europe’s leading organization for cataract and refractive surgeons in Copenhag…

Read the full story

Monday, August 22, 2016 | Acquisitions/Mergers, Presbia

Presbia Acquires Comprehensive Patent Portfolio for the Presbia Flexivue Microlens

Presbia announced that on August 2, 2016, its wholly-owned subsidiary, Presbia Ireland, Ltd., completed the purchase of the assets of Neoptics AG, including its intellectual property portfolio. &ld…

Read the full story

Thursday, August 11, 2016 | Medical Studies, Presbia

Outcomes of Presbia Microlens Surgeries in Korean Study Demonstrate Excellent Results

Presbia announced the 12-month results of the 14 Presbia Flexivue Microlens surgeries performed on South Korean patients by Dr. Lee Jong Ho, founder of the BalGeunSeSang (BGSS) Eye Clinic. T…

Read the full story

Monday, July 18, 2016 | Clinical Trials, Presbia

Combined Cataract and Presbia Microlens Surgeries Demonstrate Excellent Results and Patient Satisfaction in Near-Vision Improvement

Presbia announced the results reported in the May 2016 Journal of Refractive Surgery on combined cataract surgery and the implantation of the Presbia Flexivue Microlens as a solution to presbyopia. Th…

Read the full story

Friday, July 01, 2016 | Conferences, Presbia

Presbia to Participate in Aegean Cornea XIII 2016 Conference in Chania, Crete

Presbia PLC announced that it will be participating at the 13th Aegean Cornea Conference to be held in Crete. Vladimir Feingold, Presbia’s Chief Technology Officer and a Presbia board member, wi…

Read the full story

Thursday, June 16, 2016 | Management/Leadership, Presbia

Presbia Announces Appointment of Jarett Fenton as Chief Financial Officer

Presbia announced that Jarett Fenton has been appointed as its chief financial officer effective immediately. As chief financial officer, Mr. Fenton is responsible for all aspects of financial operati…

Read the full story

Tuesday, May 31, 2016 | Clinical Trials, Presbia

All Patients in Presbia Flexivue Microlens FDA Study Complete 6-Month Postoperative Visits

Presbia announced that all 421 subjects treated with the Presbia Flexivue Microlens as part of its FDA pivotal study completed their 6-month postoperative visits, one step closer to making the submiss…

Read the full story

Tuesday, March 01, 2016 | Cataract Surgery, Clinical Trials, Presbia

First Patients in Presbia Microlens FDA Study Complete 12-Month Postoperative Visits

Presbia announced that all subjects treated as part of the first stage of its FDA pivotal study completed their 12-month postoperative visits, a milestone in the FDA approval process of its Presbia Fl…

Read the full story

Monday, October 05, 2015 | Product Releases, Presbia

Presbia Introduces Disposable Microlens Inserter

Presbia is introducing its new disposable inserter for the Presbia Flexivue Microlens at the Australasian Society of Cataract and Refractive Surgeons (AUSCRS) conference held from October 7 through th…

Read the full story

Friday, September 18, 2015 | Miscellaneous, Presbia

Presbia Flexivue Microlens Implanted in More Than 1,000 Patients Worldwide

Presbia PLC announced that more than 1,000 patients worldwide have been treated with the Presbia Flexivue Microlens, according to a company news release. “We are very pleased to announce this…

Read the full story

Friday, September 04, 2015 | Clinical Trials, Presbia

Presbia to Complete Second Stage Enrollment in the FDA Pivotal Study of Presbia Flexivue Microlens

Presbia announced that it has scheduled the remaining treatments for completing the second stage enrollment of its FDA pivotal study, a milestone in the FDA approval process of its Presbia Flexivue Mi…

Read the full story

Monday, August 10, 2015 | Clinical Trials, Presbia

Presbia Surpasses Treatment of 300 Subjects as Part of the US FDA Pivotal Study Enrollment

Presbia announced that it is approaching completion of patient enrollment of its FDA pivotal study for the Presbia Flexivue Microlens, according to a company news release. The company will submit its …

Read the full story